# Raashid Luqmani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/raashid-luqmani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 40,038 |
| Field | Vasculitis and related conditions |
| h-index | 86 |
| i10-index | 226 |
| Last Known Institution | Nuffield Orthopaedic Centre |
| OpenAlex ID | https://openalex.org/A5017331418 |
| ORCID iD | https://orcid.org/0000-0002-4446-5841 |
| Works | 586 |

## Researcher papers

Showing 12 of 15.

- [2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides](https://scholariq.org/papers/2012-revised-international-chapel-hill-consensus-conference-nomenclature-of-2/)
- [Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis](https://scholariq.org/papers/rituximab-versus-cyclophosphamide-in-anca-associated-renal-vasculitis/)
- [Modification and validation of the Birmingham Vasculitis Activity Score (version 3)](https://scholariq.org/papers/modification-and-validation-of-the-birmingham-vasculitis-activity-score-version/)
- [EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis](https://scholariq.org/papers/eular-era-edta-recommendations-for-the-management-of-anca-associated-vasculitis/)
- [Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis](https://scholariq.org/papers/mepolizumab-or-placebo-for-eosinophilic-granulomatosis-with-polyangiitis/)
- [EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-anca-associated-vasculitis-2022/)
- [2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative](https://scholariq.org/papers/2012-provisional-classification-criteria-for-polymyalgia-rheumatica-a-european/)
- [A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis](https://scholariq.org/papers/a-multicenter-randomized-double-blind-placebo-controlled-trial-of-adjuvant/)
- [A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score](https://scholariq.org/papers/a-disease-specific-activity-index-for-wegener-s-granulomatosis-modification-of/)
- [Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up](https://scholariq.org/papers/pulse-versus-daily-oral-cyclophosphamide-for-induction-of-remission-in-anca/)
- [BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis](https://scholariq.org/papers/bsr-and-bhpr-guideline-for-the-management-of-adults-with-anca-associated/)
- [Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status](https://scholariq.org/papers/genome-wide-association-study-of-eosinophilic-granulomatosis-with-polyangiitis/)

## Researcher topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions-2/)
- [Otitis Media and Relapsing Polychondritis](https://scholariq.org/topics/otitis-media-and-relapsing-polychondritis/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

## Researcher university

- [Nuffield Orthopaedic Centre](https://scholariq.org/institutions/nuffield-orthopaedic-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.